Cargando…

Clinical characteristics and surgical history of Taiwanese patients with mucopolysaccharidosis type II: data from the hunter outcome survey (HOS)

BACKGROUND: Mucopolysaccharidosis type II (MPS II) is the most frequently occurring MPS in Taiwan, with an incidence of 2.05 per 100,000 live male births, but little is known about clinical characteristics and surgical history in Taiwanese patients. METHODS: Medical history, demographics, signs and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hsiang-Yu, Chuang, Chih-Kuang, Chen, Ming-Ren, Lin, Shio Jean, Chiu, Pao Chin, Niu, Dau-Ming, Tsai, Fuu-Jen, Hwu, Wuh-Liang, Chien, Yin-Hsiu, Lin, Ju-Li, Lin, Shuan-Pei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987665/ https://www.ncbi.nlm.nih.gov/pubmed/29866148 http://dx.doi.org/10.1186/s13023-018-0827-1

Ejemplares similares

Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA
por: Lin, Hsiang-Yu, et al.
Publicado: (2014)

Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series
por: Lin, Hsiang-Yu, et al.
Publicado: (2016)

Relationships among Height, Weight, Body Mass Index, and Age in Taiwanese Children with Different Types of Mucopolysaccharidoses
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995–2012
por: Lin, Hsiang-Yu, et al.
Publicado: (2016)

Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985–2019)
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
por: Lin, Hsiang-Yu, et al.
Publicado: (2018)

Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharidoses
por: Lin, Hsiang‐Yu, et al.
Publicado: (2019)

Functional independence of Taiwanese patients with mucopolysaccharidoses
por: Lee, Chung‐Lin, et al.
Publicado: (2019)

Natural progression of cardiac features and long-term effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis II
por: Lin, Hsiang-Yu, et al.
Publicado: (2021)

Identification and Functional Characterization of IDS Gene Mutations Underlying Taiwanese Hunter Syndrome (Mucopolysaccharidosis Type II)
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta
por: Lin, Hsiang-Yu, et al.
Publicado: (2015)

Birth weight in patients with mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS)
por: Bodamer, Olaf, et al.
Publicado: (2017)

Mutant EXT1 in Taiwanese Patients with Multiple Hereditary Exostoses
por: Lin, Wei-De, et al.
Publicado: (2014)

Intrafamilial variability in the clinical manifestations of mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS)
por: Ficicioglu, Can, et al.
Publicado: (2017)

Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)
por: Muenzer, Joseph, et al.
Publicado: (2017)

Heterogeneous nonataxic phenotypes of spinocerebellar ataxia in a Taiwanese population
por: Chen, Szu‐Ju, et al.
Publicado: (2019)

Cardiac Evaluation Using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Quantitative DNA Methylation Analysis and Epigenotype-Phenotype Correlations in Taiwanese Patients with Beckwith-Wiedemann Syndrome
por: Lin, Hsiang-Yu, et al.
Publicado: (2021)

Functional Independence of Taiwanese Children with Osteogenesis Imperfecta
por: Syu, Yu-Min, et al.
Publicado: (2022)

Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes
por: Kuo, Chieh‐Wen, et al.
Publicado: (2020)

Endoscopic and Image Analysis of the Airway in Patients with Mucopolysaccharidosis Type IVA
por: Lee, Yi-Hao, et al.
Publicado: (2023)

Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Bio-Plex immunoassay measuring the quantity of lysosomal N-acetylgalactosamine-6-sulfatase protein in dried blood spots for the screening of mucopolysaccharidosis IVA in newborn: a pilot study
por: Chuang, Chih-Kuang, et al.
Publicado: (2017)

Epigenotype, Genotype, and Phenotype Analysis of Taiwanese Patients with Silver–Russell Syndrome
por: Lin, Hsiang-Yu, et al.
Publicado: (2021)

RUNX2 mutations in Taiwanese patients with cleidocranial dysplasia
por: Lin, Wei-De, et al.
Publicado: (2011)

A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan
por: Lin, Shuan-Pei, et al.
Publicado: (2013)

Otorhinolaryngological Management in Taiwanese Patients with Mucopolysaccharidoses
por: Lee, Chung-Lin, et al.
Publicado: (2021)

Quantification of Idua Enzymatic Activity Combined with Observation of Phenotypic Change in Zebrafish Embryos Provide a Preliminary Assessment of Mutated idua Correlated with Mucopolysaccharidosis Type I
por: Lin, Cheng-Yung, et al.
Publicado: (2022)

Evaluation of the long-term treatment effects of intravenous idursulfase in patients with mucopolysaccharidosis II (MPS II) using statistical modeling: data from the Hunter Outcome Survey (HOS)
por: Muenzer, Joseph, et al.
Publicado: (2021)

Efficacy of Intravenous Elosulfase Alfa for Mucopolysaccharidosis Type IVA: A Systematic Review and Meta-Analysis
por: Lee, Chung-Lin, et al.
Publicado: (2022)

Newborn Screening Program for Mucopolysaccharidosis Type II and Long-Term Follow-Up of the Screen-Positive Subjects in Taiwan
por: Lin, Hsiang-Yu, et al.
Publicado: (2022)

Effect of Mutated ids Overexpression on IDS Enzyme Activity and Developmental Phenotypes in Zebrafish Embryos: A Valuable Index for Assessing Critical Point-Mutations Associated with Mucopolysaccharidosis Type II Occurrence in Humans
por: Lin, Cheng-Yung, et al.
Publicado: (2020)

The first SHORT syndrome in a Taiwanese boy: A case report and review of the literature
por: Lee, Chung-Lin, et al.
Publicado: (2021)

Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome
por: Lin, Han-Yi, et al.
Publicado: (2022)

Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidoses
por: Lin, Hsiang-Yu, et al.
Publicado: (2013)

A rare case of mucopolysaccharidosis: Hunter syndrome
por: Gajula, Prathima, et al.
Publicado: (2012)

Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease()
por: Chien, Yin-Hsiu, et al.
Publicado: (2017)

Clinical Presentation of Mucopolysaccharidosis Type II (Hunter's Syndrome)
por: Chinawa, JM, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_plj3hpcqlurfc3s531u6qf6hr5